Tag: Lilly
Eli Lilly down on announcement of Point Biopharma Global takeover, cancer specialist
(AOF) – Eli Lilly (-2.28% to $522.97) is down slightly on Wall Street after the announcement of the takeover of the company Point Biopharma Global. Specializing in the development of…
Lilly Becker: Honest words after the divorce from Boris
Lilly Becker Honest words after the divorce from Boris © Gisela Schober / Getty Images After five years of separation, Lilly Becker and Boris Becker are now officially divorced. In…
Boris + Lilly Becker: After 5 years! Divorce almost through
Lilly + Boris Becker Divorce almost through! Now the court has to agree © Alexander Scheuber / Getty Images Five years after their separation, Lilly and Boris Becker’s divorce will…
Boris + Lilly Becker: After 5 years! They are officially divorced
Lilly + Boris Becker They are officially divorced © Alexander Scheuber / Getty Images Five years after their separation, Lilly and Boris Becker are now finally officially divorced. Already going…
Parents collect donations – Lilly (3) suffers from life-threatening allergies
The little Tyrolean (3) suffers from a life-threatening nut allergy. There is only one special therapy in the USA that can help her – and possibly even put her out…
Lilly Becker: She shares a new photo of her son Amadeus Becker
The star news of the day in the GALA ticker: Lilly Becker shares a new photo of son Amadeus +++ Evelyn Burdecki suddenly shows up with a baby +++ Amira…
Lilly and co: Positive data in thyroid cancer
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Eli Lilly: the takeovers of Versanis and Sigilon are completed
(CercleFinance.com) – Eli Lilly announced on Monday that it had completed the acquisition of Versanis Bio, a biopharmaceutical company which it had formalized the acquisition last month for an amount…
Lilly completes the acquisition of DICE Therapeutics – 08/10/2023 at 14:28
(AOF) – Eli Lilly and Company has completed the acquisition of DICE Therapeutics, Inc. This acquisition expands Lilly’s immunology portfolio to include DICE’s novel oral therapeutic candidates, including oral IL-17…
Eli Lilly: stable with a brokerage raise
(CercleFinance.com) – The day after a jump of nearly 15%, Eli Lilly managed to maintain its equilibrium at the start of the session on Wall Street, supported by an increase…
Eli Lilly: Acquisition of DICE Therapeutics Completed
(CercleFinance.com) – Eli Lilly announced today that it has completed the acquisition of DICE Therapeutics, allowing it to expand its immunology portfolio to include new oral therapeutic candidates from DICE,…
Eli Lilly: results of a study for Alzheimer’s
(CercleFinance.com) – The group presented the results of the Phase 3 study on donanemab at the Alzheimer’s Association conference and published in JAMA. ‘Donanemab significantly slowed cognitive and functional decline…